Immix Biopharma Correlations
IMMX Stock | USD 1.97 0.32 19.39% |
The current 90-days correlation between Immix Biopharma and Bright Minds Biosciences is 0.12 (i.e., Average diversification). The correlation of Immix Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Immix Biopharma Correlation With Market
Average diversification
The correlation between Immix Biopharma and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and DJI in the same portfolio, assuming nothing else is changed.
Immix |
Moving together with Immix Stock
0.69 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.7 | INKT | Mink Therapeutics | PairCorr |
0.63 | PIRS | Pieris Pharmaceuticals | PairCorr |
0.62 | RGNX | Regenxbio | PairCorr |
0.65 | ACRV | Acrivon Therapeutics, | PairCorr |
0.63 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.7 | AFMD | Affimed NV | PairCorr |
0.66 | STOK | Stoke Therapeutics | PairCorr |
0.69 | BDTX | Black Diamond Therap | PairCorr |
Moving against Immix Stock
0.76 | OPT | Opthea | PairCorr |
0.46 | MNOV | MediciNova | PairCorr |
0.44 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.69 | ABEO | Abeona Therapeutics | PairCorr |
0.43 | TCBPW | TC BioPharm plc | PairCorr |
0.41 | CRVS | Corvus Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Immix Stock performing well and Immix Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immix Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DRUG | 49.12 | 28.18 | 2.88 | (0.77) | 4.62 | 9.23 | 1,471 | |||
HPQ | 1.31 | 0.03 | 0.02 | 0.15 | 1.62 | 2.22 | 6.13 | |||
INTC | 2.36 | 0.04 | 0.07 | 0.14 | 2.58 | 6.36 | 18.29 | |||
CVX | 0.90 | 0.07 | 0.02 | 0.22 | 1.05 | 2.21 | 5.13 | |||
KO | 0.68 | (0.15) | 0.00 | (1.28) | 0.00 | 1.11 | 4.00 | |||
TRV | 1.08 | 0.15 | 0.11 | 0.27 | 1.17 | 1.93 | 11.31 | |||
JNJ | 0.61 | (0.10) | 0.00 | (0.37) | 0.00 | 1.40 | 3.25 | |||
JPM | 1.12 | (0.01) | 0.06 | 0.12 | 1.42 | 2.05 | 15.87 | |||
MSFT | 0.90 | (0.03) | (0.04) | 0.07 | 1.49 | 2.09 | 8.19 |
Immix Biopharma Corporate Management
JD MBA | CoFounder | Profile | |
David Marks | Chief Therapy | Profile | |
Gabriel BA | CFO Director | Profile | |
Gerhard Bauer | Head Manufacturing | Profile | |
MD FFPM | Chief Development | Profile | |
Nandan BS | Manufacturing Chemistry | Profile | |
MBA MD | Chairman CoFounder | Profile |